Archives for April 27, 2004

← 2004

Osteoporosis sees new wave of treatment options

Osteoporosis sufferers are set to benefit from an influx of new drug treatments which are expected to dominate the market and give patients an unprecedented choice of treatment options, according to new market research which suggetss the size of the...

DMV ramps up excipient capacity with new plant

DMV International, the industrial ingredients division of the Netherlands' Campina, is planning to open a dedicated facility in Germany for the production of excipients for direct compression.

DSM outperforms expectations in 1Q

DSM has said it expects 'clearly higher' net profit from ordinary operations in 2004, after reporting an unexpected increase in first-quarter operating earnings.

French study evaluates consequences of REACH legislation

The impact on the French chemicals industry of implementing the European Union's REACH (Registration, Evaluation and Authorisation of Chemicals) proposals could be as high €800 million in testing alone and lead to the loss of 360,000 jobs, according...

US approval for Profile's nebuliser

Profile Therapeutics of the UK has been granted approval from the US Food and Drug Administration (FDA) for Prodose, its nebuliser system that can improve the delivery of inhaled drugs.

New granulator from L B Bohle

Germany's L B Bohle, a specialist in dispensing, granulating and milling equipment, has introduced a new granulator for pharmaceutical applications that allows for continuous throughput of materials.